Pernod Ricard (RI) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
23 Jan, 2026Executive summary
Organic net sales declined 1% (reported -4%), or grew +1% excluding Russia, as strong mature and emerging market performance offset normalization in the US and challenges in China.
Profit from recurring operations grew 1.5% organically (reported -7%), with margin expansion driven by pricing, efficiencies, and cost discipline.
Group share of net profit fell 35% year-over-year, impacted by non-recurring expenses and adverse FX.
Portfolio actively managed with disposals of local and wine brands and acquisitions in fast-growing categories, including a partnership with Almave.
Sustainability initiatives advanced, with validated emissions reduction targets and progress in distillation, packaging, transportation, and agriculture.
Financial highlights
Net sales: €11,598m, down 4% reported, down 1% organic year-over-year, with a negative FX impact of €784m.
Profit from recurring operations: €3,116m, up 1.5% organic, down 7% reported.
EPS: €7.90, down 13% year-over-year; group net profit down 35% due to non-recurring expenses and FX.
Free cash flow: €963m, down 33% year-over-year, reflecting lower profit and increased strategic investments.
Proposed dividend: €4.70 per share, flat year-over-year, with an 8.5% CAGR since FY19.
Outlook and guidance
Medium-term framework targets upper end of +4% to +7% organic net sales growth and +50–60bps operating margin expansion.
FY25 expected to return to organic net sales growth and sustain margin, with a soft Q1 due to US inventory adjustments and weak China macro.
No formal FY25 guidance yet, but rest of world expected to perform well despite US and China headwinds.
Latest events from Pernod Ricard
- Sales and profit fell, but free cash flow improved and medium-term growth targets reaffirmed.RI
H1 202619 Feb 2026 - Q1 organic sales fell 7.6%, but H2 is expected to improve as key markets recover.RI
Q1 20263 Feb 2026 - Q1 sales declined 5.9% organically, with China and US driving the downturn; guidance unchanged.RI
Q1 202519 Jan 2026 - Stable sales, margin gains, and a €4.70 dividend headline a governance-focused AGM.RI
AGM 202415 Jan 2026 - Margin and cash flow improved despite sales and profit declines amid FX and China headwinds.RI
H1 20259 Jan 2026 - Resilient results, stable dividends, and all resolutions approved amid global challenges.RI
AGM 202527 Dec 2025 - Q3 FY25 organic net sales fell 3%, but FY25 outlook and €2.35 dividend were confirmed.RI
Q3 202521 Dec 2025 - Organic sales fell 3% but margin and cash flow improved; FY26 to be a transition year.RI
H2 202523 Nov 2025 - Sharpened pricing, focused portfolio, and stronger wholesaler ties drive renewed brand momentum.RI
Investor Update18 Nov 2025